A similar trend was observed in Dvl3-knockdown MHCC-97L cells, and there was a reduction in the incidence of tumor formation with injection of 5 × 104 Dvl3-knockdown cells as well as a delay in tumor onset (Supplementary Figure 3A). The gene discussed is DVL3; the disease is neoplasm.